MedTrace Logo

Health Partner Evaluation at Princeton

NCT03386786 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2020-01-02

No results posted yet for this study

Summary

This is a prospective, single-center, randomized, comparative, controlled study. Penn Medicine Princeton Medical Center will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Subjects will be randomized to either the treatment group (Health Partner alongside standard care) or the control group (standard care alone). Health Partner is a combination of a mobile application and a web-based portal. The primary objective is to compare care plan adherence (pre- and post-surgery) for Health Partner vs. control subjects. Secondary objectives include evaluating all-cause medical resource utilization, communication with health care provider, well-being, fear of surgery, confidence in recovery from surgery, sleep, and patient satisfaction for 90 days post-surgery.

Conditions

  • Total Knee Arthroplasty; Total Hip Arthroplasty

Interventions

BEHAVIORAL

Health Partner

Health Partner is a combination of a mobile application and a web-based portal.

BEHAVIORAL

Standard Care

Patients randomized to Control will receive pre-printed brochures that outline the steps of the care plan for unilateral TKA and THA, as per standard care provided to any unilateral TJA patient receiving care at Princeton Healthcare System (PHCS).

Sponsors & Collaborators

  • Johnson & Johnson Health and Wellness Solutions, Inc.

    collaborator INDUSTRY

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Juliet Puorro, MSN, BN · Penn Medicine Princeton Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2019-12-11
Completion
2019-12-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03386786 on ClinicalTrials.gov